Delivery Order SPE2DB22D2211-SPE2DB25FSDBU
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $22,966.57 delivery order for Vivitrol 380 mg vial-diluents, with a completion date of August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,154.63 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used primarily for opioid use...
- The Defense Logistics Agency awarded a delivery order valued at $11,451.68 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. The contract is firm fixed price, non-competitive set-aside, with an ultimate completion date of July 29, 2025, just one day following the award date of July 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $3,017.66 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $14,758.51 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Vivitrol 380 mg vials with diluents, valued at $6,007.02. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and is classified as a delivery order, with an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,003.51 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract was executed on July 23, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Vivitrol 380 mg vial-diluents with a ceiling value of $3,862.11. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,762.71 for Vivitrol 380 mg vial-diluents on August 14, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 15, 2025 and serves the Defense Logistics Agency's Medical Supply Chain. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $10,234.10 delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, a medication used primarily for opioid use disorder treatment. This firm fixed-price contract, with a completion date of July 30, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDBUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,365.11 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This competitively awarded, firm fixed-price contract was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. The award carries no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military and federal healthcare systems globally. Vivitrol, an extended-release naltrexone formulation used in opioid use disorder treatment, represents one component of the company's extensive pharmaceutical portfolio supporting defense health programs and the Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 8/18/25 |